ISHP Research Fellowship

In alignment with its statutes, the ISHP is committed to fostering research, education, and dissemination in pharmaceutical history. Consequently, the Society will continue to endorse research projects of global significance within pharmaceutical history, including a €2,500 grant.
This grant is predominantly aimed at scholarly endeavors, though not exclusively so. Submission of proposals for the 2025 ISHP Fellowship Grant is required to be emailed in English to the ISHP General Secretary by August 31, 2024. Proposals should encompass:

• A comprehensive description of the research project, typically (though not mandatorily) conducted within an academic framework
• An extensive discourse on the project’s international relevance
• The applicant’s curriculum vitae
• The relevant national organization’s confirmation of the applicant’s ISHP membership
• A record of the applicant’s prior research projects and publications
• A recommendation letter from a senior academic advisor
• A detailed enumeration of anticipated expenses (e.g., travel costs, literature acquisition)

A fellowship committee consisting of the ISHP President, the General Secretary, and three eminent scholars in pharmaceutical history appointed by the Select Executive Committee will evaluate proposals.
The successful candidate’s obligations include presenting the project at the ISHP General Assembly or another suitable venue during the International Congress for the History of Pharmacy in 2026. Following the project’s conclusion, detailed outcomes (e.g., a comprehensive report and reprints of publications) must be submitted to ISHP. Furthermore, annual progress reports are expected in December each year until the project’s completion.

Prof. Dr. Dusanka Krajnovic

ISHP General Secretary

List of Fellowship recipients


Kayoko Shimada-Takaura, Japan: The exploration of the suites of crude drug specimens collected around early 20th century reflecting the region specific ‘medicinal culture’.


Florian Eidam-Weber, Germany: Ethnopharmaceutical research by the Austrian tibetologist and ethnologist René Nebesky-Wojkowitz (1923–1959).

Dr. Tünde Ambrus, Czech Republic: Historical sources and cultural heritage of pharmaceutical activities of the Hospitaller Order of St. John of God in the Central European Region.

Samaneh Soleymani, Iran: Classification of Persian and Arabic Pharmaceutical books and treatises in Islamic civilization (8th to 18th century CE)

Markus Maxim, Germany: Transmission of medical-pharmaceutical knowledge between East Africa and Europe in the context of the Bethel Missions in the 20th century.

Yohko Natsume, Japan: Research on the development of pharmaceutical theory in ancient India; the Bower Manuscript.

Paulina Oszajca, Poland: Theriac and its’ derivatives in the Early Modern Europe society (16th – 18th century); a comparative study.

Jelena Manojlovic, Serbia: The art of pharmaceutical care. Influence of the Habsburg Monarchy and the Ottoman Empire on the skills and doctrine of pharmaceutical care in countries of South-Eastern Europe in the period from the 16th to the 18th century; a comparative study.

Juris Salaks, Latvia: The operations of F. Hofmann-La Roche in Russia from 1896 until 1920

Dimitrios Koutroumpas: Galen’s Pharmacology: Simple medicines and their theoretical model according to Galen

Joan E. Taylor, United Kingdom: The Essenes and Dead Sea Pharmacology

Maki Umemura, Japan: History of the post-war Japanese pharmaceutical industry

Svetlana Hautala, Italy: Communication of the pharmaceutical knowledge in Hellenistic Greece: the case of itinerant vendors of remedies

Ute Mauch, Germany: Alexander Hispanus and his medical compendium – critical appraisal of the ‘Melleus liquor physicae artis’ with a historical depiction of the pharmaceutical plants contained therein

Sabine Anagnostou, Germany: Missionary pharmacy – Christian mission – international drug transfer – change of materiae medicae (16.–18.c.)

Andreea Nitulescu, Doina Draganescu: Relationship between pharmaceutical legislation from several European countries after the First World War – the pathway to the present pharmaceutical legislation in the European Union.